Clinical Trial Update: FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating FEC chemotherapy with G-CSF support followed by ixabepilone with G-CSF support in breast cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEC regimen (fluorouracil/epirubicin/cyclophosphamide) with G-CSF
• Ixabepilone (Ixempra) (ixabepilone)

Snippet

Sponsor: Consorzio Oncotech | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED